Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MRP1 Antibody (IU2H10) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 13 publications
Supplier: Novus Biologicals NB400156SS
Description
MRP1 Monoclonal specifically detects MRP1 in Human, Mouse, Rat samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, CyTOF-ready, Dual RNAscope ISH-IHC.Specifications
MRP1 | |
Monoclonal | |
1.0 mg/mL | |
Western Blot 1:500, Flow Cytometry reported in scientific literature, ELISA reported in scientific literature, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1:50-1:200, Immunoprecipitation reported in scientific literature, CyTOF-ready, Dual RNAscope ISH-IHC | |
ABC29, ABCC, ATP-binding cassette sub-family C member 1, ATP-binding cassette, sub-family C (CFTR/MRP), member 1, EC 3.6.3, EC 3.6.3.44, GS-X, Leukotriene C(4) transporter, LTC4 transporter, MRP1DKFZp781G125, MRPDKFZp686N04233, multidrug resistance associated protein 1, multidrug resistance protein, multidrug resistance-associated protein 1, multiple drug resistance protein 1, multiple drug resistance-associated protein | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
Human, Mouse, Rat | |
Purified |
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, CyTOF | |
IU2H10 | |
Unconjugated | |
P33527 | |
ABCC1 | |
Recombinant peptide (a.a. 1-33) of human MRP1. [UniProt# P33527]. | |
0.025 mL | |
ABC Transporters, Amino Acids Drugs and other small molecules, Cancer, Lipid and Metabolism, Plasma Membrane Markers, Signal Transduction | |
4363 | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction